Breast Cancer Research

Breast Cancer Research

Research into breast cancer at Penn State Cancer Institute is conducted by a dedicated breast cancer team. See current clinical trials and members of that team here.

Clinical Trials

COG-ALTE05N1
Umbrella Long-term Follow-up Protocol
PSCI-16-031
PALLAS: PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer
PSCI-16-053
A Single Arm Phase II Study of Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-016
PSCI-17-021
A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination with Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-024
PSHCI-08-079
Children's Lives Include Moments of Bravery (CLIMB)
PSHCI-09-011
Role of TRP Channel Isoforms in Breast Cancer
PSHCI-10-025
Patterns of Patient Care in Appalachia
PSHCI-10-100
An Observational Trial of the Phase I and II Metabolism Profile of Exemestane in Breast Cancer Patients
PSHCI-12-119
Clinicopathologic Study of Breast Cancer
PSHCI-15-001
Sirtuin 3 (SIRT3): A Novel Predictive Biomarker for Tamoxifen Resistance
PSHCI-15-025
Predicting Breast Cancer Metastasis: Signaling Pathway Biomarker Identification Using Reverse Phase Protein Microarray (RPMA) Technology
RYBKA-2002-198EP
Protocol for a Research Database for Hematopoietic Cell Transplantation, other Cellular Therapies and Marrow Toxic Injuries.

Disease Team Members

First Name Last Name Title Role
Ayodele Ayoola, MD Ayodele Ayoola MD View Profile
Alison Chetlen, DO Alison Chetlen DO View Profile
Leah Cream, MD Leah Cream MD View Profile
Daleela Dodge, MD Daleela Dodge MD View Profile
Harold Harvey, MD Harold Harvey MD View Profile
Claudia Kasales, MD Claudia Kasales MD View Profile
Rena Kass, MD Rena Kass MD View Profile
Julie Mack, MD Julie Mack MD View Profile
Rogerio Neves, MD, PhD Rogerio Neves MD, PhD View Profile
Melody Paulishak, DO Melody Paulishak DO View Profile
John Potochny John Potochny View Profile
Jennifer Rosenberg, MD Jennifer Rosenberg MD View Profile
Marc Rovito, MD Marc Rovito MD View Profile
Susann Schetter, DO Susann Schetter DO View Profile
Rebecca Sivarajah, MD Rebecca Sivarajah MD View Profile
Cristina Truica, MD Cristina Truica MD View Profile
Meredith Watts, MD Meredith Watts MD View Profile
Kristine Widders, MD Kristine Widders MD View Profile
Nicholas Zaorsky, MD Nicholas Zaorsky MD View Profile
Research into breast cancer at Penn State Cancer Institute is conducted by a dedicated breast cancer team. See current clinical trials and members of that team here.

Clinical Trials
COG-ALTE05N1
Umbrella Long-term Follow-up Protocol
PSCI-16-031
PALLAS: PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer
PSCI-16-053
A Single Arm Phase II Study of Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-016
PSCI-17-021
A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination with Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-024
PSHCI-08-079
Children's Lives Include Moments of Bravery (CLIMB)
PSHCI-09-011
Role of TRP Channel Isoforms in Breast Cancer
PSHCI-10-025
Patterns of Patient Care in Appalachia
PSHCI-10-100
An Observational Trial of the Phase I and II Metabolism Profile of Exemestane in Breast Cancer Patients
PSHCI-12-119
Clinicopathologic Study of Breast Cancer
PSHCI-15-001
Sirtuin 3 (SIRT3): A Novel Predictive Biomarker for Tamoxifen Resistance
PSHCI-15-025
Predicting Breast Cancer Metastasis: Signaling Pathway Biomarker Identification Using Reverse Phase Protein Microarray (RPMA) Technology
RYBKA-2002-198EP
Protocol for a Research Database for Hematopoietic Cell Transplantation, other Cellular Therapies and Marrow Toxic Injuries.

Disease Team Members
First Name Last Name Title Role
Ayodele Ayoola, MD Ayodele Ayoola MD View Profile
Alison Chetlen, DO Alison Chetlen DO View Profile
Leah Cream, MD Leah Cream MD View Profile
Daleela Dodge, MD Daleela Dodge MD View Profile
Harold Harvey, MD Harold Harvey MD View Profile
Claudia Kasales, MD Claudia Kasales MD View Profile
Rena Kass, MD Rena Kass MD View Profile
Julie Mack, MD Julie Mack MD View Profile
Rogerio Neves, MD, PhD Rogerio Neves MD, PhD View Profile
Melody Paulishak, DO Melody Paulishak DO View Profile
John Potochny John Potochny View Profile
Jennifer Rosenberg, MD Jennifer Rosenberg MD View Profile
Marc Rovito, MD Marc Rovito MD View Profile
Susann Schetter, DO Susann Schetter DO View Profile
Rebecca Sivarajah, MD Rebecca Sivarajah MD View Profile
Cristina Truica, MD Cristina Truica MD View Profile
Meredith Watts, MD Meredith Watts MD View Profile
Kristine Widders, MD Kristine Widders MD View Profile
Nicholas Zaorsky, MD Nicholas Zaorsky MD View Profile

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)